PharmaShots | Incisive News in 3 Shots

Subscribe Now

Heterozygous Familial Hypercholesterolemia

Amgen's Repatha (evolocumab) Receives the US FDA's Approval for the Treatment of Heterozygous Familial Hypercholesterolemia

Amgen's Repatha (evolocumab) Receives the US FDA's Approval for the Treatment of Heterozygous Familial Hypercholesterolemia

September 27, 2021

Innovent's IBI306 Meets its Primary Endpoint in P-III CREDIT-2 Study for Heterozygous Familial Hypercholesterolemia

Innovent's IBI306 Meets its Primary Endpoint in P-III CREDIT-2 Study for Heterozygous Familial Hypercholesterolemia

August 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us